# Effect of Silymarin in Rheumatoid Arthritis Patients Treated With Methotrexate

> **NCT06724952** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Tanta University** · enrollment: 44 (estimated)

## Conditions studied

- Rheumatoid Arthritis (RA)

## Interventions

- **DRUG:** MTX S.C or IM and Silymarin 140 mg tab
- **DRUG:** MTX S.C or IM

## Key facts

- **NCT ID:** NCT06724952
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-10
- **Primary completion:** 2025-03-10
- **Final completion:** 2025-04-10
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06724952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06724952, "Effect of Silymarin in Rheumatoid Arthritis Patients Treated With Methotrexate". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT06724952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*